TWENTY-MONTH OUTCOME IN VENTILATOR-DEPENDENT, VERY-LOW-BIRTH-WEIGHT INFANTS BORN DURING THE EARLY YEARS OF DEXAMETHASONE THERAPY

被引:26
作者
FURMAN, L
HACK, M
WATTS, C
BORAWSKICLARK, E
BALEY, J
AMINI, S
HOOK, B
机构
[1] CASE WESTERN RESERVE UNIV, DEPT PEDIAT, CLEVELAND, OH 44106 USA
[2] CASE WESTERN RESERVE UNIV, DEPT EPIDEMIOL, CLEVELAND, OH 44106 USA
关键词
D O I
10.1016/S0022-3476(95)70464-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We sought to examine the effect of the introduction of dexamethasone therapy on health, growth, and neurodevelopmental outcome in very low birth weight (VLBW) infants at 20 months of age. We compared outcomes in all 86 VLBW infants (mean birth weight 871 gm, mean gestational age 26.4 weeks) who were ventilator dependent on day 21 of life during the 2 years preceding October 1988 (period 1), when dexamethasone therapy became accepted clinical practice in our unit, with outcomes in all 124 infants (mean birth weight 891 gm, mean gestational age 26.9 weeks) with similar ventilator status during the subsequent 2 years (period 2), In addition, we compared outcomes in infants who received dexamethasone during period 2 with those in a concurrent cohort of less ill infants who were not given dexamethasone. There were no significant differences between periods 1 and 2 in mortality rates after 21 days (17% vs 21%), need for home oxygen (23% vs 25%), oxygen dependence at 20 months of corrected age (11% vs 10%), rate of neurosensory impairment (24% vs 25%), and mean Bayley Mental scores (81.5 vs 77.2) or Psychomotor Development Index (81.6 vs 71.1), Infants who received dexamethasone during period 2 had significantly more severe lung disease and poorer respiratory, growth, and developmental outcomes, We conclude that VLBW infants with ventilator-dependent chronic lung disease have very poor outcomes even when treated with dexamethasone. More information is needed from prospective, randomized trials before dexamethasone can be accepted as routine therapy for chronic lung disease.
引用
收藏
页码:434 / 440
页数:7
相关论文
共 33 条
[1]  
AMIELTISON C, 1976, CURRENT PROBLEMS PED, V7
[2]  
AVERY GB, 1985, PEDIATRICS, V75, P106
[3]  
AVERY ME, 1987, PEDIATRICS, V79, P26
[4]  
Bayley N., 1993, BAYLEY SCALES INFANT, V2nd Edn
[5]   NEURODEVELOPMENTAL OUTCOME IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA [J].
BREGMAN, J ;
FARRELL, EE .
CLINICS IN PERINATOLOGY, 1992, 19 (03) :673-694
[6]   FACTORS ASSOCIATED WITH CHRONIC LUNG-DISEASE IN PRETERM INFANTS [J].
COOKE, RWI .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1991, 66 (07) :776-779
[7]  
CORDERO L, 1993, RESP CARE, V38, P1355
[8]   A CONTROLLED TRIAL OF DEXAMETHASONE IN PRETERM INFANTS AT HIGH-RISK FOR BRONCHOPULMONARY DYSPLASIA [J].
CUMMINGS, JJ ;
DEUGENIO, DB ;
GROSS, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (23) :1505-1510
[9]   AMELIORATION OF BRONCHOPULMONARY DYSPLASIA AFTER VITAMIN-E ADMINISTRATION - PRELIMINARY-REPORT [J].
EHRENKRANZ, RA ;
BONTA, BW ;
ABLOW, RC ;
WARSHAW, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (11) :564-569
[10]  
Ehrenkranz Richard A., 1992, P399